Stonepine Capital Management, LLC Castle Biosciences Inc Transaction History

Stonepine Capital Management, LLC

  • $158 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$11.66 - $26.0 $2.34 Million - $5.22 Million
-200,888 Reduced 68.59%
91,978 $1.26 Million
Q1 2023

May 12, 2023
BUY
$19.47 - $28.49 $2.23 Million - $3.27 Million
114,626 Added 64.31%
292,866 $6.65 Million
Q4 2022

Feb 14, 2023
BUY
$18.08 - $30.0 $3.22 Million - $5.35 Million
178,240 New
178,240 $4.2 Million
Q2 2022

Aug 12, 2022
BUY
$16.0 - $45.99 $4.73 Million - $13.6 Million
295,372 New
295,372 $6.48 Million

Others Institutions Holding CSTL

# of Institutions
201
Shares Held
24.5M
Call Options Held
303K
Put Options Held
30.3K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $752M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email